Ganesan Suresh M, Morrisey Joanne M, Ke Hangjun, Painter Heather J, Laroiya Kamal, Phillips Margaret A, Rathod Pradipsinh K, Mather Michael W, Vaidya Akhil B
Center for Molecular Parasitology, Department of Microbiology and Immunology, Drexel University College of Medicine, 2900 W. Queen Lane, Philadelphia, PA 19129, USA.
Mol Biochem Parasitol. 2011 May;177(1):29-34. doi: 10.1016/j.molbiopara.2011.01.004. Epub 2011 Jan 18.
Genetic manipulation of Plasmodium falciparum in culture through transfection has provided numerous insights into the molecular and cell biology of this parasite. The procedure is rather cumbersome, and is limited by the number of drug-resistant markers that can be used for selecting transfected parasites. Here we report a new selectable marker that could allow multiple transfections. We have taken advantage of our finding that a critical function of the mitochondrial electron transport chain (mtETC) in the erythrocytic stages of P. falciparum is the regeneration of ubiquinone as co-substrate of dihydroorotate dehydrogenase (DHODH), and that transgenic P. falciparum expressing ubiquinone-independent DHODH from yeast (yDHODH) are resistant to all mtETC inhibitors. We assessed the possibility of using yDHODH as a positive selectable marker for transfections of P. falciparum, including its use in gene disruption strategies. We constructed a transfection vector designed for gene disruption, termed pUF-1, containing the yDHODH gene as the positive selection marker in combination with a previously described fused yeast cytosine deaminase-uracil phosphoribosyl transferase gene as a negative selection marker. Transfection of the D10 strain followed by selection with atovaquone yielded positively selected parasites containing the plasmid, demonstrating that yDHODH can be used as a selective marker. Atovaquone, however, could not be used for such selection with the Dd2 strain of P. falciparum. On the other hand, we demonstrated that yDHODH transgenic parasites could be selected in both strains by Plasmodium DHODH-specific triazolopyrimidine-based inhibitors. Thus, selection with DHODH inhibitors was superior in that it successfully selected transgenic Dd2 parasites, as well as yielded transgenic parasites after a shorter period of selection. As a proof of concept, we have successfully disrupted the type II vacuolar proton-pumping pyrophosphatase gene (PfVP2) in P. falciparum by double crossover recombination, showing that this gene is not essential for the survival of blood stage parasites.
通过转染在体外对恶性疟原虫进行基因操作,为深入了解该寄生虫的分子和细胞生物学提供了大量信息。该过程相当繁琐,且受限于可用于筛选转染寄生虫的耐药标记数量。在此,我们报告一种可实现多次转染的新型选择标记。我们利用了这一发现:恶性疟原虫红细胞内期线粒体电子传递链(mtETC)的一项关键功能是作为二氢乳清酸脱氢酶(DHODH)的共底物再生泛醌,并且表达来自酵母的不依赖泛醌的DHODH(yDHODH)的转基因恶性疟原虫对所有mtETC抑制剂均具有抗性。我们评估了使用yDHODH作为恶性疟原虫转染阳性选择标记的可能性,包括其在基因敲除策略中的应用。我们构建了一种用于基因敲除的转染载体,命名为pUF - 1,其包含yDHODH基因作为阳性选择标记,并结合了先前描述的融合酵母胞嘧啶脱氨酶 - 尿嘧啶磷酸核糖转移酶基因作为阴性选择标记。用阿托伐醌对D10株进行转染并筛选后,得到了含有该质粒的阳性选择寄生虫,这表明yDHODH可作为选择标记。然而,阿托伐醌不能用于对恶性疟原虫Dd2株进行此类筛选。另一方面,我们证明基于三唑并嘧啶的疟原虫DHODH特异性抑制剂可在两种菌株中筛选出yDHODH转基因寄生虫。因此,使用DHODH抑制剂进行筛选具有优势,因为它成功筛选出了转基因Dd2寄生虫,并且在较短的筛选期后也产生了转基因寄生虫。作为概念验证,我们通过双交换重组成功敲除了恶性疟原虫中的II型液泡质子泵焦磷酸酶基因(PfVP2),表明该基因对于血期寄生虫的存活并非必需。